FAIRFAX, Va., June 4, 2026 /PRNewswire/ -- Allergy & Asthma Network CEO Lynda Mitchell issued the following statement in response to the Centers for Medicare & Medicaid Services...
New fully integrated module inside the i21 ERP platform delivers end-to-end automation for terminal operators - from BOL import to motor fuel tax compliance...
ALEXANDRIA, Va., June 4, 2026 /PRNewswire/ -- As communities across Virginia are experiencing a summer expected to bring above-normal temperatures and drier-than-average conditions, Virginia American...
HighlightsExploration Permit Applications filed for:Phase 2 Diamond Drilling at the Pt. Leamington VMS Deposit targeting deposit resource upgrade / expansion of the emerging Kraken...
HighlightsExploration Permit Applications filed for:Phase 2 Diamond Drilling at the Pt. Leamington VMS Deposit targeting deposit resource upgrade / expansion of the emerging Kraken...
Rapid Expansion of Wi-Fi 7 Leaves Adoption HeadroomREDWOOD CITY, Calif., June 4, 2026 /PRNewswire/ -- According to a recently published report from Dell'Oro Group, the...
NEW YORK, June 4, 2026 /PRNewswire/ -- In response to shifting demand across professional and everyday settings, Better Business Advice has recognized Quay for its...
ST. GALLEN, Switzerland and LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ: SRAD), a leading global sports technology company creating immersive experiences for sports fans and bettors, today announced a multi-year extension of its data and audiovisual (AV) betting rights agreement for The Championships, Wimbledon. The rights were originally secured as part of the company’s acquisition of IMG ARENA in 2025.
Five-stop trade show roadmap across Germany, Spain and Poland to showcase transducerized tightening, servo pressing, automated screw feeding and precision dispensing solutionsMUNICH, June 4,...
SINGAPORE, June 04, 2026 (GLOBE NEWSWIRE) -- Rankpage has launched AIRM, an AI Reputation Management system developed to help businesses monitor, analyse, manage, and improve how their brands appear across AI-generated answers.
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).